Literature DB >> 15012921

Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction.

Erik Kjøller1, Lars Køber, Kasper Iversen, Christian Torp-Pedersen.   

Abstract

AIMS: To evaluate the importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. METHOD AND
RESULTS: Prospective registration of 6669 consecutive patients admitted with infarction and screened for a randomised controlled trial. A history of COPD was present in 765 (11.5%) patients. Thirty-day and 5-year survival in patients with chronic obstructive pulmonary disease was 86.3 and 42.9%. In patients without pulmonary disease the figures were 87.7 and 57.5%, respectively, giving a relative risk of 1.49 (1.35-1.65). In multivariate analysis the relative risk was 1.15 (1.04-1.28). The prevalence of congestive heart failure was 65.9% in patients with chronic obstructive pulmonary disease and 52.0% in patients without. This difference was most distinct in patients with normal or only slightly decreased left ventricular systolic function. In patients without congestive heart failure, chronic obstructive pulmonary disease was of prognostic importance [RR=1.44 (1.17-1.78)], but not in patients with congestive heart failure [RR=1.09 (0.96-1.23)].
CONCLUSION: Chronic obstructive pulmonary disease is a predictor of long-term mortality in patients with acute myocardial infarction without congestive heart failure, but is also a confounding factor for the diagnosis of congestive heart failure.

Entities:  

Mesh:

Year:  2004        PMID: 15012921     DOI: 10.1016/j.ejheart.2003.09.008

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  13 in total

1.  Chronic obstructive pulmonary disease after myocardial infarction in the community.

Authors:  Francesca Bursi; Robert Vassallo; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

2.  [COPD and heart disease].

Authors:  H Watz; M Arzt
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

3.  Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry.

Authors:  Jonathan R Enriquez; Shailja V Parikh; Faith Selzer; Alice K Jacobs; Oscar Marroquin; Suresh Mulukutla; Vankeepuram Srinivas; Elizabeth M Holper
Journal:  Chest       Date:  2011-04-28       Impact factor: 9.410

4.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Authors:  Nathaniel M Hawkins; Zhen Huang; Karen S Pieper; Scott D Solomon; Lars Kober; Eric J Velazquez; Karl Swedberg; Marc A Pfeffer; John J V McMurray; Aldo P Maggioni
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

5.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

6.  COPD in patients with stable heart failure in the primary care setting.

Authors:  Mark J Valk; Berna D Broekhuizen; Arend Mosterd; Nicolaas P Zuithoff; Arno W Hoes; Frans H Rutten
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-26

7.  Prevalence of airflow obstruction in patients with stable systolic heart failure.

Authors:  Morten Dalsgaard; Louis Lind Plesner; Morten Schou; Erik Kjøller; Jørgen Vestbo; Kasper Iversen
Journal:  BMC Pulm Med       Date:  2017-01-06       Impact factor: 3.317

8.  Prospective care of heart failure in Japan: lessons from CHART studies.

Authors:  Nobuyuki Shiba; Hiroaki Shimokawa
Journal:  EPMA J       Date:  2011-07-09       Impact factor: 6.543

Review 9.  Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

Authors:  Kieran J Rothnie; Ruoling Yan; Liam Smeeth; Jennifer K Quint
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

10.  Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.

Authors:  J K Quint; E Herrett; K Bhaskaran; A Timmis; H Hemingway; J A Wedzicha; L Smeeth
Journal:  BMJ       Date:  2013-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.